We are live on ! Find out more
AHPI

Allied Healthcare Products

Delisted

AHPI was delisted on the 2nd of February, 2023.

9 hedge funds and large institutions have $886K invested in Allied Healthcare Products in 2017 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

3% more capital invested

Capital invested by funds: $861K → $886K (+$25K)

0% more funds holding

Funds holding: 99 (0)

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

Holders
9
Holders Change
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
3
Reduced
2
Closed
1
Calls
Puts
Net Calls
Net Calls Change

AHPI Hedge Fund Activity: Q4 2017 in Review

9 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Allied Healthcare Products (AHPI) for Q4 2017, worth a combined $886K — up 2.9% from $861K a quarter earlier.

Fund positioning in AHPI was balanced in Q4 2017: 1 fund opened new positions, 1 closed out, 3 added to existing stakes and 2 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $24.7K. The largest seller was Wells Fargo, cutting an estimated $15.5K.

  • 9 institutional investors held Allied Healthcare Products (AHPI) as of Q4 2017, unchanged from Q3 2017.
  • Funds reported $886K of Allied Healthcare Products stock for Q4 2017, up 2.9% quarter-over-quarter.
  • 1 fund opened new Allied Healthcare Products positions in Q4 2017 and 1 closed out, a net change of 0 holders.
  • The largest Allied Healthcare Products buyer in Q4 2017 was Renaissance Technologies, an estimated $24.7K added.
  • The largest Allied Healthcare Products seller in Q4 2017 was Wells Fargo, an estimated $15.5K sold.

Based on aggregated 13F filings for Q4 2017.